Chemolieve

A 4-day meal program currently undergoing clinical testing at five different hospitals to evaluate whether it supports the body during chemotherapy and helps with decreasing side effects and recovery. Chemolieve® clinical trials are being conducted at the University of Southern California, Mayo Clinic, Leiden University, and the University of Genoa.

Chemolieve® is the first 4-day meal replacement based on proprietary dietary interventions to supply the body with important nutrients to reduce adverse side effects of chemotherapy.